Researcher’s Profile

David J. Cohen, MD

Americas Top Doctor : 
1
Medical Director, Renal Transplantation
Overview: 

I am interested in immunosuppressive drug protocols in renal transplantation, as well as renal disease occurring in recipients of non-renal transplants.

Publications: 
Wilkinson AH, Cohen DJ. (1999) Renal failure in recipients of non-renal solid organ transplants. J Amer Soc Nephrol 10:1136-45
The Mycophenolate Mofetil Acute Rejection Study Group. (2001) Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. Transplantation 71:1091-7
Lin J, Valeri AM, Cohen DJ, Radhakrishnan J. (2002) Angiotensin converting enzyme (ACE) inhibition in chronic allograft nephropathy. Transplantation 73:783-8
Adams PL, Cohen DJ, Danovitch GM, et al. (2002) The nondirected live-kidney donor: ethical considerations and practice guidelines. Transplantation 74:582-90
About: 

I am involved in numerous clinical protocols investigating new immunosuppressive drugs and/or new combinations of existing medications in renal transplant patients, both newly transplanted patients and those with long-term functioning transplants.